Connacht Asset Management LP Nevro Corp Transaction History

Connacht Asset Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $255,598 - $485,981	-6,257 Reduced 33.35%	12,505 $548,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $207,846 - $319,172	-3,467 Reduced 15.6%	18,762 $1.36 Million
Q4 2021 Feb 11, 2022	BUY	$81.07 - $121.29 $703,201 - $1.05 Million	8,674 Added 63.99%	22,229 $1.8 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $1.38 Million - $2.26 Million	13,555 New	13,555 $1.58 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.